Decentralising drug-resistant TB treatment initiation services
IJTLD Open · 2025-12 · 2 (12) · 757-762
DOI: 10.5588/ijtldopen.25.0412 ↗Kurz gefasst
Fachartikel in der Zeitschrift IJTLD Open, online erschienen am 01.12.2025. Verfasst von N Murphy-Okpala und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Programs, RedAid Nigeria, Enugu, Nigeria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND Drug-resistant TB (DR-TB) care coordination in Nigeria remains largely centralised, negatively impacting pre-treatment loss-to-follow-up (PTLTFU) and time-to-treatment initiation. We piloted a multi-faceted intervention and documented how the decentralisation of DR-TB services affected treatment enrolment and time-to-treatment initiation. METHODS A quasi-experimental study was conducted in Southern Nigeria. Multi-level intervention consisting of eight components was implemented in the intervention states over a 15-month period. Data were collected using desk review proformas and analysed. RESULTS At baseline, comparable proportions of people with DR-TB initiated treatment (χ 2 = 3.150, P = 0.076). Following decentralisation, a higher proportion (79.1%) of diagnosed persons with DR-TB in the intervention states were enrolled into treatment compared with the control states, 66.0% (χ 2 = 15.232, P < 0.001). There was a significant reduction in PTLTFU in the intervention states from 39.5% to 20.9% ( P < 0.001) while PTLTFU increased from 31.9% to 34.0% ( P = 0.689) in the control states. The median time-to-treatment initiation decreased from 17 days (interquartile range [IQR]: 10.0–32.0) at baseline to 14 days (IQR: 9.0–25.2) post-intervention. In the control states, median time-to-treatment initiation decreased from 21 days (IQR: 13.0–35.3) at baseline to 15 days (8.0–36.0) post-intervention. CONCLUSION Decentralising DR-TB services significantly reduced the diagnosis–enrolment gap and time-to-treatment initiation. Our findings provide contextual evidence for the expansion of decentralised services in Nigeria.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Programs, RedAid Nigeria, Enugu, Nigeria.
- Department of Medical Microbiology, Faculty of Basic Clinical Sciences, College of Medicine, University of Nigeria Ituku-Ozalla Campus, Enugu, Nigeria.
- Department of Community Medicine, University of Nigeria Teaching Hospital, Ituku-Ozalla, Nigeria.
- New Dimension Consulting, Dar es Salaam, Tanzania.
- Stop TB Partnership, Geneva, Switzerland.
- Department of Community Medicine, Faculty of Health Sciences, Ebonyi State University, Abakaliki, Nigeria.
ORCID-Profile: N Murphy-Okpala
Zitieren
APA
Murphy-Okpala, N., Eze, C., Orabueze, I. N., Ezenwosu, I., Nwafor, C., Ekeke, N., Ezeakile, O., Chukwu, J. N., Matiku, S., Meka, A., Njoku, M., Kirubi, B., Iyama, F., Ossai, E., Chijioke-Akaniro, O., & Creswell, J. (2025). Decentralising drug-resistant TB treatment initiation services. IJTLD Open, 2(12), 757-762. https://doi.org/10.5588/ijtldopen.25.0412
Vancouver
Murphy-Okpala N, Eze C, Orabueze IN, Ezenwosu I, Nwafor C, Ekeke N, et al. Decentralising drug-resistant TB treatment initiation services. IJTLD Open. 2025;2(12):757-762. doi:10.5588/ijtldopen.25.0412
BibTeX
@article{MurphyOkpala2025,
author = {Murphy-Okpala, N and Eze, C and Orabueze, I N and Ezenwosu, I and Nwafor, C and Ekeke, N and Ezeakile, O and Chukwu, J N and Matiku, S and Meka, A and Njoku, M and Kirubi, B and Iyama, F and Ossai, E and Chijioke-Akaniro, O and Creswell, J},
title = {Decentralising drug-resistant TB treatment initiation services},
journal = {IJTLD Open},
year = {2025},
volume = {2},
number = {12},
pages = {757--762},
doi = {10.5588/ijtldopen.25.0412}
}
EUVIMED